Bal Pharma Limited (NSE:BALPHARMA)
65.88
-1.01 (-1.51%)
Mar 27, 2026, 3:29 PM IST
Bal Pharma Revenue
Bal Pharma had revenue of 876.90M INR in the quarter ending December 31, 2025, with 19.87% growth. This brings the company's revenue in the last twelve months to 3.09B, down -2.02% year-over-year. In the fiscal year ending March 31, 2025, Bal Pharma had annual revenue of 3.03B, down -10.65%.
Revenue (ttm)
3.09B
Revenue Growth
-2.02%
P/S Ratio
0.34
Revenue / Employee
3.14M
Employees
986
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.03B | -361.36M | -10.65% |
| Mar 31, 2024 | 3.39B | 350.03M | 11.51% |
| Mar 31, 2023 | 3.04B | 230.02M | 8.18% |
| Mar 31, 2022 | 2.81B | 306.86M | 12.25% |
| Mar 31, 2021 | 2.51B | 794.34M | 46.43% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nectar Lifesciences | 16.70B |
| Ind-Swift Laboratories | 5.94B |
| Sigachi Industries | 4.85B |
| Valiant Laboratories | 2.03B |
| Bafna Pharmaceuticals | 1.47B |
| Alpa Laboratories | 1.14B |
| Vaishali Pharma | 1.14B |
| Par Drugs and Chemicals | 1.06B |